Product Program year 2024 Source: CMS Open Payments

EnCor

Device Vascular/Oncology

PDI 10801741086691

Open in the dashboard

General payments

$29,388

57 payments

Research payments

$0

0 payments

Through program year 2024, $29,388 in general payments and $0 in research payments were reported against EnCor (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2024 General $28,914 42
2023 General $474 15

Breakdown

Who paid General payments · program years 2023–2024
  1. Bard Peripheral Vascular, Inc. $29,307 54 payments
  2. Davol Inc. $47 1 payment
  3. Becton, Dickinson and Company $35 2 payments
Top recipients General payments · program year 2024
  1. Jeremy Schiller Diagnostic Radiology · Cambridge, MA $1,750 6% · 1 payment
  2. Douglas Burd Diagnostic Radiology · Templeton, MA $1,750 6% · 1 payment
  3. Salomao Faintuch Diagnostic Ultrasound · Boston, MA $1,750 6% · 1 payment
  4. Clement Grassi Diagnostic Radiology · Boston, MA $1,750 6% · 1 payment
  5. Robert Faberman Diagnostic Radiology · Holyoke, MA $1,750 6% · 1 payment

The top 5 of 41 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Diagnostic Radiology Radiology $25,006 86% · 27 practitioners
  2. Orthopaedic Surgery $1,750 6% · 1 practitioner
  3. Diagnostic Ultrasound Radiology $1,750 6% · 1 practitioner
  4. Surgery $312 1% · 8 practitioners
  5. Anatomic Pathology Pathology $33 <1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Massachusetts $28,000 97% · 16 recipients
  2. Missouri $169 <1% · 9 recipients
  3. Nevada $137 <1% · 1 recipient
  4. California $116 <1% · 1 recipient
  5. Indiana $80 <1% · 2 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

57 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record